clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Kleine-Levin Syndrome D017593 1 associated lipids
Granuloma, Plasma Cell D006104 1 associated lipids
Epilepsy, Partial, Motor D020938 1 associated lipids
Cutaneous Fistula D017577 1 associated lipids
Tuberculosis, Ocular D014392 1 associated lipids
Encephalomyelitis, Acute Disseminated D004673 1 associated lipids
Empyema, Tuberculous D004654 1 associated lipids
Euthyroid Sick Syndromes D005067 1 associated lipids
Immune Reconstitution Inflammatory Syndrome D054019 1 associated lipids
Serositis D012700 1 associated lipids
Parotid Diseases D010305 1 associated lipids
Glossitis, Benign Migratory D005929 1 associated lipids
Achlorhydria D000126 1 associated lipids
Extensively Drug-Resistant Tuberculosis D054908 1 associated lipids
Sacroiliitis D058566 1 associated lipids
Eye Infections D015817 1 associated lipids
Upper Extremity Deep Vein Thrombosis D056824 1 associated lipids
Pseudomyxoma Peritonei D011553 1 associated lipids
Buruli Ulcer D054312 1 associated lipids
Gastritis, Hypertrophic D005758 1 associated lipids
Myxoma D009232 1 associated lipids
Tuberculosis, Spinal D014399 1 associated lipids
Hypoproteinemia D007019 1 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Mastoiditis D008417 2 associated lipids
Periodontal Abscess D010508 2 associated lipids
Cytomegalovirus Retinitis D017726 2 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Iritis D007500 2 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Still's Disease, Adult-Onset D016706 2 associated lipids
Monoclonal Gammopathy of Undetermined Significance D008998 2 associated lipids
IgA Deficiency D017098 2 associated lipids
Eye Injuries, Penetrating D015807 2 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Leprosy, Lepromatous D015440 2 associated lipids
Discitis D015299 2 associated lipids
Iris Diseases D007499 2 associated lipids
Angiomatosis, Bacillary D016917 2 associated lipids
Tooth, Nonvital D019553 2 associated lipids
Tuberculosis, Avian D014379 2 associated lipids
Immunoproliferative Small Intestinal Disease D007161 2 associated lipids
Hyperemesis Gravidarum D006939 2 associated lipids
Cardiovascular Abnormalities D018376 2 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Leprosy, Paucibacillary D056005 2 associated lipids
Typhoid Fever D014435 2 associated lipids
Soft Tissue Infections D018461 2 associated lipids
Empyema, Pleural D016724 2 associated lipids
Diphtheria D004165 2 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Kim SY et al. Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy. 2013 J. Clin. Gastroenterol. pmid:22647826
Fagoonee S et al. Efficacy of cefixime-based triple therapy for Helicobacter pylori eradication: a retrospective study. 2013 Panminerva Med pmid:24088806
Gisbert JP et al. Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients. 2013 J. Clin. Gastroenterol. pmid:22647827
Schmidt BJ and Hermansen MN [Late debut of neonatal pneumonia caused by Chlamydia trachomatis]. 2013 Ugeskr. Laeg. pmid:23428270
Yu Q et al. Treatment of pulmonary mucosa-associated lymphoid tissue lymphoma with clarithromycin. 2013 Chin. Med. J. pmid:23786961
Duman DG et al. Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats. 2013 Br. J. Nutr. pmid:23279717
Lahbabi M et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: result of the HPFEZ randomised study. 2013 Clin Res Hepatol Gastroenterol pmid:23168228
Secka O et al. Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa. 2013 Antimicrob. Agents Chemother. pmid:23263004
Mueck W et al. Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects. 2013 Br J Clin Pharmacol pmid:23305158
Karmakar S et al. Hypokalemia: a potent risk for QTc prolongation in clarithromycin treated rats. 2013 Eur. J. Pharmacol. pmid:23567068
Benajah DA et al. Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco). 2013 Clin Res Hepatol Gastroenterol pmid:23567104
Abenavoli L et al. Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. 2013 Med. Hypotheses pmid:24011768
Faraji F et al. The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. 2012 Nov-Dec Pain Physician pmid:23159967
Eremenko AA et al. [Effect of clarithromycin on the systemic inflammatory response syndrome severity in patients after myocardial revascularization surgery]. 2012 May-Jun Anesteziol Reanimatol pmid:22993930
Singh V et al. Vesicular palmoplantar pityriasis rosea. 2012 Mar-Apr Skinmed pmid:22545332
Gutiérrez-Castrellón P et al. Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis. 2012 Mar-Apr Rev. Invest. Clin. pmid:22991774
Rajendiran S et al. Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment. 2012 Jul-Aug Saudi J Gastroenterol pmid:22824768
De Sanctis V et al. Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum. 2012 Jul-Aug Tumori pmid:23052174
Figueroa M et al. [Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis]. 2012 Jan-Mar Biomedica pmid:23235785
de Lalibera IB et al. Meningoencephalitis associated with Mycoplasma pneumoniae. 2012 Jan-Mar Einstein (Sao Paulo) pmid:23045836
Dhillon GS et al. Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients. 2012 Jan-Feb Clin Transplant pmid:21352378
Onsun N et al. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. 2012 Jan-Feb Eur J Dermatol pmid:22063790
Montero-Tinnirello J et al. [Pulmonary hemorrhage due to leptospirosis]. 2012 Jan-Feb Med Intensiva pmid:21592620
Dai WQ et al. The eradicating Helicobacter pylori infection in duodenal ulcer patients by three short-term triple therapies in China: a multicenter clinical comparative study. 2012 Jan-Feb Hepatogastroenterology pmid:22260837
Stout JE and Floto RA Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than others. 2012 Am. J. Respir. Crit. Care Med. pmid:23118083
Mouktaroudi M and Giamarellos-Bourboulis EJ Macrolides for the therapy of nosocomial infections. 2012 Curr. Opin. Infect. Dis. pmid:22248975
Yakoob J et al. Prevalence of non Helicobacter pylori species in patients presenting with dyspepsia. 2012 BMC Gastroenterol pmid:22226326
Perez AP et al. Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels. 2012 Int J Nanomedicine pmid:22457595
Kumar R et al. Synthesis and antibacterial activity of a novel series of acylides active against community acquired respiratory pathogens. 2012 Bioorg. Med. Chem. Lett. pmid:22153939
Choi HS et al. Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. 2012 World J. Gastroenterol. pmid:22654429
Majima Y et al. Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp. 2012 Auris Nasus Larynx pmid:21636230
Shakya N et al. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors. 2012 Bioorg. Med. Chem. pmid:22664188
Milani M et al. The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics. 2012 J. Infect. Chemother. pmid:22581031
Perić A et al. Effect of long-term, low-dose clarithromycin on T helper 2 cytokines, eosinophilic cationic protein and the 'regulated on activation, normal T cell expressed and secreted' chemokine in the nasal secretions of patients with nasal polyposis. 2012 J Laryngol Otol pmid:22559798
Stepanić V et al. Physicochemical profile of macrolides and their comparison with small molecules. 2012 Eur J Med Chem pmid:22152985
González-Martínez R et al. Antibiotic prescription in the treatment of odontogenic infection by health professionals: a factor to consensus. 2012 Med Oral Patol Oral Cir Bucal pmid:22143715
Greenstein RJ et al. Vitamins A & D inhibit the growth of mycobacteria in radiometric culture. 2012 PLoS ONE pmid:22235314
Chung JW et al. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance. 2012 J. Gastroenterol. Hepatol. pmid:21793912
von Müller L et al. [Current data and trends on the development of antibiotic resistance of Clostridium difficile]. 2012 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz pmid:23114440
Davies BS et al. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London. 2012 Scand. J. Infect. Dis. pmid:23078529
Cajigas-Pezo D et al. [Swelling of right knee in an immunologically compromised patient]. 2012 Enferm. Infecc. Microbiol. Clin. pmid:22521279
Aguilar JA et al. Decoupling two-dimensional NMR spectroscopy in both dimensions: pure shift NOESY and COSY. 2012 Angew. Chem. Int. Ed. Engl. pmid:22588724
Yoon JH et al. Trends in the eradication rates of Helicobacter pylori infection for eleven years. 2012 World J. Gastroenterol. pmid:23236238
Al-Abri SS et al. An audit of inpatient management of community-acquired pneumonia in Oman: a comparison with regional clinical guidelines. 2012 J Infect Public Health pmid:22632599
Shih HY et al. Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese Population. 2012 Gastroenterol Res Pract pmid:22829808
Sanaei Dashti A et al. Nasopharyngeal carrier rate of Streptococcus pneumoniae in children: serotype distribution and antimicrobial resistance. 2012 Arch Iran Med pmid:22827788
Cao S et al. Pharmacokinetic interactions between ilaprazole and clarithromycin following ilaprazole, clarithromycin and amoxicillin triple therapy. 2012 Acta Pharmacol. Sin. pmid:22820908
Saito R et al. Molecular mechanism of macrolide-lincosamide resistance in Moraxella catarrhalis. 2012 J. Med. Microbiol. pmid:22820696
Kido T et al. Two cases of primary ciliary dyskinesia with different responses to macrolide treatment. 2012 Intern. Med. pmid:22576394
Flamm RK et al. Macrolide and tetracycline resistance among Moraxella catarrhalis isolates from 2009 to 2011. 2012 Diagn. Microbiol. Infect. Dis. pmid:22819241
Girgis DO et al. Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management. 2012 Clin. Experiment. Ophthalmol. pmid:21902780
Kuo CH et al. The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012. 2012 Gastroenterol Res Pract pmid:22792095
Marzouk H et al. The utility of nasopharyngeal culture in the management of chronic adenoiditis. 2012 Int. J. Pediatr. Otorhinolaryngol. pmid:22784508
Dore MP et al. Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures. 2012 Gastroenterol Res Pract pmid:22666234
Lange JN et al. Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics. 2012 Urology pmid:22656407
Blumenthal A et al. M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection. 2012 PLoS ONE pmid:22649518
Sugimoto M and Furuta T Efficacy of esomeprazole in treating acid-related diseases in Japanese populations. 2012 Clin Exp Gastroenterol pmid:22649281
Henneman A and Thornby KA Risk of hypotension with concomitant use of calcium-channel blockers and macrolide antibiotics. 2012 Am J Health Syst Pharm pmid:22644980
Gatta L et al. Treatment of Helicobacter pylori in Latin America. 2012 Lancet pmid:22305217
Dicicco M et al. Efficacy of clarithromycin on biofilm formation of methicillin-resistant Staphylococcus pseudintermedius. 2012 BMC Vet. Res. pmid:23171620
Graham DY and Trespalacios AA Treatment of Helicobacter pylori in Latin America. 2012 Lancet pmid:22305218
Noguchi S et al. Clarithromycin form I determined by synchrotron X-ray powder diffraction. 2012 Acta Crystallogr C pmid:22307251
Soares DN et al. Cross-sectional microhardness of bovine enamel subjected to three paediatric liquid oral medicines: an in vitro study. 2012 Eur Arch Paediatr Dent pmid:23043884
Loghmari H et al. Clarithromycin versus metronidazole in first-line Helicobacter pylori eradication. Prospective randomized study of 85 Tunisian adults. 2012 Tunis Med pmid:22311445
Shiota S et al. Association of helicobacter pylori dupA with the failure of primary eradication. 2012 J. Clin. Gastroenterol. pmid:22298090
Bayles T et al. Clarithromycin for community-acquired pneumonia: beware drug interactions. 2012 Intern Med J pmid:23046194
Liang JH et al. Structure-activity relationships of novel alkylides: 3-O-arylalkyl clarithromycin derivatives with improved antibacterial activities. 2012 Eur J Med Chem pmid:22301216
Lembo G et al. Successful treatment of Mycobacterium terrae complex infection of the knee. 2012 J Clin Rheumatol pmid:23047536
Rudramurthy M et al. Nasal vestibulitis due to Nocardiopsis dassonvillei in a diabetic patient. 2012 J. Med. Microbiol. pmid:22556323
Zhou YQ et al. Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study. 2012 Gastroenterol Res Pract pmid:22550478
Kamijo F et al. A Case of Mycobacterial Skin Disease Caused by Mycobacterium peregrinum, and a Review of Cutaneous Infection. 2012 Case Rep Dermatol pmid:22548041
Talebi Bezmin Abadi A et al. Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. 2012 Intern Emerg Med pmid:21437583
Goodman JJ and Martin SI Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections. 2012 Ther Clin Risk Manag pmid:22547933
Werth S et al. Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery. 2012 Ther Clin Risk Manag pmid:22547932
Arora S and Budhiraja RD Chitosan-alginate microcapsules of amoxicillin for gastric stability and mucoadhesion. 2012 J Adv Pharm Technol Res pmid:22470897
Rozza AL et al. Morphologic and pharmacological investigations in the epicatechin gastroprotective effect. 2012 Evid Based Complement Alternat Med pmid:22666296
Czekalski N et al. Increased levels of multiresistant bacteria and resistance genes after wastewater treatment and their dissemination into lake geneva, Switzerland. 2012 Front Microbiol pmid:22461783
Khan GA et al. The development and application of a system for simultaneously determining anti-infectives and nasal decongestants using on-line solid-phase extraction and liquid chromatography-tandem mass spectrometry. 2012 J Pharm Biomed Anal pmid:22459504
Gisbert JP and Calvet X Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori. 2012 Clin Exp Gastroenterol pmid:22457599
Hahn DL et al. Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. 2012 PLoS ONE pmid:22545149
Wang H et al. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010]. 2012 Zhonghua Jie He He Hu Xi Za Zhi pmid:22455967
Noto MJ and Wheeler AP Macrolides for acute lung injury. 2012 Chest pmid:22553255
Onoe H et al. Buruli ulcer accompanied by pain in a Japanese patient. 2012 J. Dermatol. pmid:22168180
Zautner AE Adenotonsillar disease. 2012 Recent Pat Inflamm Allergy Drug Discov pmid:22452646
Peters J et al. Clarithromycin is absorbed by an intestinal uptake mechanism that is sensitive to major inhibition by rifampicin: results of a short-term drug interaction study in foals. 2012 Drug Metab. Dispos. pmid:22170330
Li Y et al. Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days. 2012 J Dig Dis pmid:22188917
Chang CS et al. Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells. 2012 Eur J Med Chem pmid:22217866
Kargar M et al. Real-time PCR for Helicobacter pylori quantification and detection of clarithromycin resistance in gastric tissue from patients with gastrointestinal disorders. 2012 Res. Microbiol. pmid:22177975
Srivastav NC et al. Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs. 2012 Bioorg. Med. Chem. Lett. pmid:22178557
Youn YS and Lee KY Mycoplasma pneumoniae pneumonia in children. 2012 Korean J Pediatr pmid:22375148
Gisbert JP et al. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures. 2012 Aliment. Pharmacol. Ther. pmid:22372560
Maselli DJ et al. Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia. 2012 Infect Drug Resist pmid:22355258
Iino R et al. A microfluidic device for simple and rapid evaluation of multidrug efflux pump inhibitors. 2012 Front Microbiol pmid:22347225
Dholakia Y et al. Drug-resistant tuberculosis: Study of clinical practices of chest physicians, Maharashtra, India. 2012 Lung India pmid:22345911
Carlos CA et al. Mycobacterial infection identified with broad-range PCR amplification and suspension array identification. 2012 J. Cutan. Pathol. pmid:22764735
Tonkic A et al. Time trends of primary antibiotic resistance of Helicobacter pylori isolates in Southern Croatia. 2012 J Chemother pmid:22759765
Wang YJ et al. Rapid quantitative analysis of clarithromycin in rat plasma by UPLC-MS/MS after intravenous injection of the clarithromycin-loaded ultrafine PLGA nanoparticles. 2012 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:22483396
Erdur B et al. Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance. 2012 J. Pediatr. Gastroenterol. Nutr. pmid:22465935
McNulty CA et al. Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered? 2012 Aliment. Pharmacol. Ther. pmid:22469191
Jakopović IP et al. Novel desosamine-modified 14- and 15-membered macrolides without antibacterial activity. 2012 Bioorg. Med. Chem. Lett. pmid:22503348